Cargando…
Evaluation of Biased and Balanced Salvinorin A Analogs in Preclinical Models of Pain
In the search for safer, non-addictive analgesics, kappa opioid receptor (KOPr) agonists are a potential target, as unlike mu-opioid analgesics, they do not have abuse potential. Salvinorin A (SalA) is a potent and selective KOPr agonist, however, clinical utility is limited by the short duration of...
Autores principales: | Paton, Kelly F., Biggerstaff, Andrew, Kaska, Sophia, Crowley, Rachel S., La Flamme, Anne C., Prisinzano, Thomas E., Kivell, Bronwyn M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385413/ https://www.ncbi.nlm.nih.gov/pubmed/32792903 http://dx.doi.org/10.3389/fnins.2020.00765 |
Ejemplares similares
-
The Salvinorin Analogue, Ethoxymethyl Ether Salvinorin B, Promotes Remyelination in Preclinical Models of Multiple Sclerosis
por: Paton, Kelly F., et al.
Publicado: (2021) -
Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents
por: Kivell, Bronwyn M., et al.
Publicado: (2018) -
Sex Differences in Kappa Opioid Receptor Agonist Mediated Attenuation of Chemotherapy-Induced Neuropathic Pain in Mice
por: Paton, Kelly F., et al.
Publicado: (2022) -
Synthesis and κ-Opioid
Receptor Activity
of Furan-Substituted Salvinorin A Analogues
por: Riley, Andrew P., et al.
Publicado: (2014) -
Studies
toward the Development of Antiproliferative
Neoclerodanes from Salvinorin A
por: Vasiljevik, Tamara, et al.
Publicado: (2014)